Holen Sie sich die Stockscreener-App
65.97
0.21%
-0.14
Handel nachbörslich:
65.97
Schlusskurs vom Vortag:
$66.11
Offen:
$66.01
24-Stunden-Volumen:
348.44K
Relative Volume:
0.83
Marktkapitalisierung:
$3.12B
Einnahmen:
$1.11B
Nettoeinkommen (Verlust:
$200.84M
KGV:
16.36
EPS:
4.0314
Netto-Cashflow:
$255.45M
1W Leistung:
-1.58%
1M Leistung:
+2.81%
6M Leistung:
+3.26%
1J Leistung:
-23.26%
1-Tages-Spanne:
$64.97
$66.81
1-Wochen-Bereich:
$63.69
$68.62
52-Wochen-Spanne:
$57.25
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Firmenname
Prestige Consumer Healthcare Inc
Sektor
Telefon
(914) 524-6800
Adresse
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
65.97 | 3.13B | 1.11B | 200.84M | 255.45M | 4.0314 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Hochstufung | Sidoti | Neutral → Buy |
| 2024-12-09 | Herabstufung | Sidoti | Buy → Neutral |
| 2024-06-21 | Hochstufung | DA Davidson | Neutral → Buy |
| 2022-11-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-05-10 | Hochstufung | Jefferies | Hold → Buy |
| 2022-05-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-06-29 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-04-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-04-07 | Fortgesetzt | Sidoti | Neutral |
| 2020-03-26 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-24 | Eingeleitet | Oppenheimer | Perform |
| 2020-03-19 | Hochstufung | DA Davidson | Neutral → Buy |
| 2019-01-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Hochstufung | Jefferies | Underperform → Hold |
| 2017-05-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Bestätigt | B. Riley & Co. | Buy |
| 2016-11-17 | Eingeleitet | Gabelli & Co | Buy |
| 2016-08-12 | Hochstufung | Sidoti | Neutral → Buy |
| 2016-03-08 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-11-30 | Herabstufung | Jefferies | Hold → Underperform |
| 2014-04-28 | Bestätigt | B. Riley & Co. | Buy |
| 2014-04-28 | Bestätigt | Oppenheimer | Outperform |
| 2013-07-09 | Eingeleitet | B. Riley & Co. | Buy |
Alle ansehen
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
Fundamentals Check: What is Prestige Consumer Healthcare Incs 5 year growth outlookJobs Report & Real-Time Volume Analysis - baoquankhu1.vn
How Prestige Consumer Healthcare Inc. stock reacts to oil prices2025 Major Catalysts & Advanced Swing Trade Entry Plans - mfd.ru
Prestige Consumer Healthcare Inc. Just Missed EarningsBut Analysts Have Updated Their Models - 富途牛牛
Prestige Consumer Healthcare narrows fiscal 2026 revenue outlook to $1.1B while advancing Clear Eyes supply recovery - MSN
Prestige Consumer Healthcare (PBH) Valuation Check After Clear Eyes Supply Headwinds And Pillar5 Acquisition - Yahoo Finance
Prestige Consumer Healthcare Inc. $PBH Stock Position Decreased by Bessemer Group Inc. - MarketBeat
Prestige Consumer Healthcare Q3 Earnings Call Highlights - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Prestige Consumer Healthcare (PBH), McKesson (MCK) and Bristol-Myers Squibb (BMY) - The Globe and Mail
Prestige Deal For Stampede Culinary Partners Reshapes Earnings And Valuation Potential - Sahm
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2026 Earnings Call Transcript - Insider Monkey
Prestige Consumer Healthcare Q3 FY26 slides: Strong cash flow offsets revenue decline By Investing.com - Investing.com South Africa
Decoding Prestige Consumer Healthcare Inc (PBH): A Strategic SWO - GuruFocus
Prestige Consumer Healthcare Q3 FY26 slides: Strong cash flow offsets revenue decline - Investing.com Nigeria
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot - theheraldreview.com
Prestige Consumer Healthcare Q3 2026 Earnings Call Transcript - MarketBeat
Prestige Consumer Healthcare Inc (PBH) Q3 2026 Earnings Call Highlights: Navigating Challenges ... By GuruFocus - Investing.com Canada
Prestige Consumer Healthcare (NYSE:PBH) Releases Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Prestige Looks Well Positioned for Durable Growth as Clear Eyes Issue Gradually Recovers - Morningstar
Earnings call transcript: Prestige Consumer Healthcare reports steady Q3 2026 results - Investing.com India
Prestige Consumer Healthcare (PBH) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
PBH Adjusts FY26 Revenue Growth Expectations - GuruFocus
Prestige Consumer Healthcare Seeks M&A - marketscreener.com
Prestige Consumer Healthcare (NYSE:PBH) Issues FY 2026 Earnings Guidance - MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) Reports Mixed Q3 FY2026 Results, Misses Analyst Estimates - Chartmill
Prestige Consumer Healthcare Q3 Earnings Miss Expectations - Intellectia AI
Prestige Consumer Healthcare (PBH) Q3 Earnings Lag Estimates - Yahoo Finance
Prestige Consumer Fiscal Q3 Adjusted Earnings, Revenue Fall; Full-Year Outlook Revised - marketscreener.com
Prestige Consumer Healthcare Q3 revenue tops estimates, narrows guidance By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare Q3 revenue tops estimates, narrows guidance - Investing.com
Prestige Consumer Healthcare Reports Q3 Results, Narrows Outlook - TipRanks
Earnings Flash (PBH) Prestige Consumer Healthcare Inc. Posts Q3 Adjusted EPS $1.14 per Share, vs. FactSet Est of $1.14 - marketscreener.com
Prestige Consumer Healthcare: Fiscal Third Quarter Earnings Overview - Bitget
Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results - The Manila Times
Prestige Consumer Healthcare Inc. SEC 10-Q Report - TradingView
Insights into Prestige Consumer Q3 Earnings - Benzinga
Prestige Consumer Health earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Prestige Consumer's Earnings: A Preview - Benzinga
Aug Spikes: Why is Prestige Consumer Healthcare Inc stock going upJuly 2025 Update & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Price-Driven Insight from (PBH) for Rule-Based Strategy - Stock Traders Daily
Prestige Consumer Healthcare (PBH) Stock Analysis: Strong Buy Ratings Signal Nearly 20% Upside Potential - DirectorsTalk Interviews
Prestige Consumer Healthcare Inc. (PBH): A bull case theory - MSN
Prestige Consumer Healthcare Inc. (PBH): A Bull Case Theory - Finviz
Jefferies Maintains "Hold" Rating on Prestige Consumer (PBH), Lo - GuruFocus
Jefferies Maintains Hold on Prestige Consumer Healthcare Inc. (PBH) Jan 30 2026 - Meyka
Retail Trends: Why is Prestige Consumer Healthcare Inc stock going up2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Great Lakes Advisors LLC Has $4.96 Million Stake in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Y Intercept Hong Kong Ltd Has $2.04 Million Stock Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare (PBH) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Market Trends: Is Eureka Acquisition Corp Debt Equity Composite Units on track to beat earningsPortfolio Value Summary & High Conviction Buy Zone Alerts - baoquankhu1.vn
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring an 18.54% Upside Potential - DirectorsTalk Interviews
Is Prestige Consumer Healthcare’s Screen-Fatigue Focus Reshaping the TheraTears Brand Narrative for PBH Investors? - Yahoo Finance
Finanzdaten der Prestige Consumer Healthcare Inc-Aktie (PBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.21%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):